NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
record initialized not assigned to examiner
on 07 Oct 2024
Last Applicant/ Owned by
545 Fifth Avenue, Suite 1400
New York
NY
10017
Serial Number
98787898 filed on 07th Oct 2024
Registration Number
N/A
Correspondent Address
Anna Kurian Shaw
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
NUGALVIQ
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for treatment of rare orphan diseases; Pharmaceutical preparations for treatment of diseases that impact sugar and glucose metabolism; Pharmaceutical preparations for inhibiting aldose reductase; Pharmaceutical preparations for treatment of galactosemia, sorbitol dehydrogenase (SORD) deficiency and PMM2-congenital disorder of glycosylation (PMM2-CDG)
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98787898
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 761350.00240
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Oct 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 07th Oct 2024 | NEW APPLICATION ENTERED |